Hearing News Watch

Featured image for “ADA Opens Registration for Inaugural Audiology Practice Accreditation Cohort”
Nov. 03, 2025

ADA Opens Registration for Inaugural Audiology Practice Accreditation Cohort

HHTM
LEXINGTON, KENTUCKY – The Academy of Doctors of Audiology (ADA) has announced that registration is now open for the inaugural cohort of the ADA Audiology Practice Accreditation Program. The registration deadline is Friday, December 5, 2025, or until a maximum of 50 practices have registered. The ADA Audiology Practice Accreditation initiative aims to help practices strengthen and streamline operations, align with
Featured image for “Beltone Continues Tradition of Giving with Third “Hear for the Holidays” Drive”
Nov. 03, 2025

Beltone Continues Tradition of Giving with Third “Hear for the Holidays” Drive

HHTM
CHICAGO, ILLINOIS – Beltone has launched its third annual Hear for the Holidays campaign, an initiative designed to help individuals with hearing loss reconnect with loved ones during the holiday season. Through December 31, people can nominate themselves or someone they know to receive a free pair of hearing aids from participating Beltone hearing centers across the United States. Recipients
Featured image for “CamGene Therapeutics Secures Oversubscribed Seed Round to Advance RNA-Based Hearing Loss Therapies”
Nov. 01, 2025

CamGene Therapeutics Secures Oversubscribed Seed Round to Advance RNA-Based Hearing Loss Therapies

HHTM
CAMBRIDGE, UNITED KINGDOM – CamGene Therapeutics, a biotechnology company developing first-in-class RNA-based therapies for hearing loss, has announced the successful closing of its oversubscribed seed funding round. The financing was led by the UK Innovation & Science Seed Fund (UKI2S), managed by Future Planet Capital, and joined by majority investor Eos Advisory, as well as Cambridge Enterprise Ventures, Hex Two, LongRiver
Featured image for “Amplifon Reports 9M 2025 Results, Citing Stronger Third-Quarter Performance”
Oct. 30, 2025

Amplifon Reports 9M 2025 Results, Citing Stronger Third-Quarter Performance

HHTM
MILAN, ITALY – Amplifon S.p.A. announced its results for the first nine months and third quarter ended September 30, 2025. The company reported revenues of €1,743.8 million (~$1.87 billion) for the first nine months, an increase of 1.8% at constant exchange rates compared to the same period in 2024. The improvement was driven by a return to organic growth in
Featured image for “Moving the Meter for Hearing Health”
Oct. 28, 2025

Moving the Meter for Hearing Health

HHTM
by Terry Mactaggart, President and CEO, Summus Hearing Inc.  My last post (Introducing Merlin – Making Hearing Care Accessible to All) summarized our view of the hearing health conundrum and what we at Summus Hearing (in concert with others) can do about it. While testing abounds online and via hearing aid dispenser/ENT networks, a significant majority of people don’t take
Featured image for “Starkey Recognized on Fast Company’s 2025 Next Big Things in Tech List”
Oct. 28, 2025

Starkey Recognized on Fast Company’s 2025 Next Big Things in Tech List

HHTM
EDEN PRAIRIE, MINNESOTA — Starkey has been named to Fast Company’s 2025 Next Big Things in Tech list, which recognizes innovations reshaping industries and advancing technology with meaningful impact. The distinction highlights Starkey’s role in developing hearing aids that function as intelligent health devices supporting communication, safety, and overall well-being. The Next Big Things in Tech list honors companies of all
Featured image for “Demant Announces Sale of Oticon Medical to Nordic Healthcare Investor Impilo”
Oct. 23, 2025

Demant Announces Sale of Oticon Medical to Nordic Healthcare Investor Impilo

HHTM
SMØRUM, DENMARK — Demant has signed an agreement to sell Oticon Medical to Nordic investment firm Impilo for a total contractual consideration of up to DKK 600 million (approximately USD $85 million). The transaction concludes Demant’s divestment of its Hearing Implants business area. The agreement ensures continuity for Oticon Medical’s operations and supports its long-term market position, future growth, and
Featured image for “HearAdvisor Announces Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards”
Oct. 22, 2025

HearAdvisor Announces Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards

HHTM
ROCKFORD, ILLINIOS — HearAdvisor, an independent audio performance lab, has announced the winners of its 2025 Expert Choice Awards, recognizing the best hearing aids and earplugs of the year. Now in its third year, the awards highlight products that deliver exceptional sound quality and performance based on rigorous, objective lab testing. HearAdvisor remains the only lab worldwide offering independent, data-driven
Featured image for “Neuromod Launches Online Tinnitus Masterclass to Support Clinician Education and Access to Care”
Oct. 21, 2025

Neuromod Launches Online Tinnitus Masterclass to Support Clinician Education and Access to Care

HHTM
DUBLIN, IRELAND — Neuromod, the medical device company behind the Lenire tinnitus treatment device, has announced the launch of Tinnitus Masterclass, an online course designed to provide hearing care professionals with clinical and commercial knowledge to establish effective and sustainable tinnitus care services. Tinnitus Masterclass is an expert-led online program that integrates audiology, neurology, and psychology into short, focused modules. The
Featured image for “Study Reveals How CPD Mutations Disrupt Cochlear Function — and How They Might Be Treated”
Oct. 19, 2025

Study Reveals How CPD Mutations Disrupt Cochlear Function — and How They Might Be Treated

HHTM
Hearing loss affects millions of people worldwide, including one in 500 newborns and nearly half of adults over age 65. Although many cases are genetic, most hereditary forms of hearing loss have long been considered irreversible. Now, new research from the University of Miami Miller School of Medicine and international collaborators has identified a genetic form of deafness that could